Antibodies to Keyhole Limpet Hemocyanin Cross-React with an Epitope on the Polysaccharide Capsule of Cryptococcus neoformans and Other Carbohydrates: Implications for Vaccine Development

Journal of Immunology

Volumn 171, Issue 9, 2003, Pages 4905-4912

  May, Rena J ^a   Beenhouwer, David O ^a,b   Scharff, Matthew D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; EPITOPE; FREUND ADJUVANT; GLUCURONOXYLOMANNAN; GLUTARALDEHYDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; KEYHOLE LIMPET HEMOCYANIN; MONOCLONAL ANTIBODY; PERIODATE SODIUM; POLYSACCHARIDE; SYNTHETIC PEPTIDE; TETANUS TOXOID; UNCLASSIFIED DRUG; VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL MODEL; ARTICLE; CROSS REACTION; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNGAL MENINGITIS; IMMUNIZATION; MOUSE; NEUROPROTECTION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; VACCINATION;

EID: 0142241395     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.9.4905     Document Type: Article

References (66)

1. Tunkel, A. R., and W. M. Scheld. 1995. Acute meningitis. In Principles and Practice of Infectious Diseases, Vol. 1. G. L. Mandell, J. E. Bennett, and R. Dolin, eds. Churchill Livingstone, New York, p. 831.
2. Austrian, R. 1985. Polysaccharide vaccines. Ann. Inst. Pasteur Microbiol. 136B: 295.
3. Mond, J. J., A. Lees, and C. M. Snapper. 1995. T cell-independent antigens type 2. Annu. Rev. Immunol. 13:655.
4. Pirofski, L. A. 2001. Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens. Trends Microbiol. 9:445.
5. Pirofski, L. A., and A. Casadevall. 1998. Use of licensed vaccines for active immunization of the immunocompromised host. Clin. Microbiol. Rev. 11:1.
6. Ahman, H., H. Kayhty, H. Lehtonen, O. Leroy, J. Froeschle, and J. Eskola. 1998. Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. Pediatr. Infect. Dis. J. 17:211.
7. Jansen, W. T., S. Hogenboom, M. J. Thijssen, J. P. Kamerling, J. F. Vliegenthart, J. Verhoef, H. Snippe, and A. F. Verheul, 2001. Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice. Infect. Immun. 69:787.
8. Robbins, J. B., R. Schneerson, P. Anderson, and D. H. Smith. 1996. The 1996 Albert Lasker Medical Research Awards: prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b: impact on public health and implications for other polysaccharide based vaccines. J. Am. Med. Assoc. 276: 1181.
9. Han, Y., T. Kanbe, R. Cherniak, and J. E. Cutler. 1997. Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies. Infect. Immum. 65:4100.
10. Ko, A. I., and D. A. Harn. 1987. Characterization of protective and non-protective surface membrane carbohydrate epitopes of Schistosoma mansoni. Mem. Inst. Oswaldo Cruz 82(Suppl. 4):115.
11. Nussbaum, G., W. Cleare, A. Casadevall, M. D. Scharff, and P. Valadon. 1997. Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. J. Exp. Med. 185:685.
12. Mukherjee, J., G. Nussbaum, M. D. Scharff, and A. Casadevall. 1995. Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J. Exp. Med. 181:405.
13. Nussbaum, G., R. Yuan, A. Casadevall, and M. D. Scharff. 1996. Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans. J. Exp. Med. 183:1905.
14. , Butterworth, A. E., R. Bensted-Smith, A. Capron, M. Capron, P. R. Dalton, D. W. Dunne, J. M. Grzych, H. C. Kariuki, J. Khalife, D. Koech, et al. 1987. Immunity in human Schistosomiasis mansoni: prevention by blocking antibodies of the expression of immunity in young children. Parasitology 94:281.
15. Joiner. K. A., R. Scales, K. A. Warren, M. M. Frank, and P. A. Rice. 1985. Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae. J. Clin. Invest. 76:1765.
16. Fleurídor, R., A. Lees, and L. Pirofski. 2001. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection, J. Immunol. 166:1087.
17. Harris. S. L., M. K. Park, M. H. Nahm, and B. Diamond. 2000. Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoaiae. Infect. Immun. 68:5778.
18. Moe, G. R., S. Tan, and D. M. Granoff. 1999. Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease. FEMS Immunol. Med. Microbiol. 26:209.
19. Valadon, P., G. Nussbaum, J. Oh, and M. D. Scharff. 1998. Aspects of antigen mimicry revealed by immunization with a peptide mimetic of Cryptococcus neoformans polysaccharide. J. Immunol. 161:1829.
20. Beenhouwer, D. O., R. May, P. Valadon, and M. Scharff. 2002. High affinity mimotope of the polysaccharide capsule of Ctyptococcus neoformans identified from an evolutionary phage peptide. J. Immunol. 169:6992.
21. Beenhouwer, D. O., P. Valadon, R. May, and M. D. Scharff. 2000. Peptide mimicry of the polysaccharide capsule of Cryptococcus neoformans, In Molecular Mimicry, Microbes and Autoimmunity. M. W. Cunningham and R. S. Fujinami, eds. ASM Press, Washington D.C., p., 143.
22. Casadevall, A. 1995. Antibody immunity and invasive fungal infections, Infect. Immun. 63:4211.
23. Valadon, P., G. Nussbaum, L. F. Boyd, D. H. Margulies, and M. D. Scharff. 1996. Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans. J. Mol. Biol. 261:11.
24. Landsteiner, K. 1945. The Specificity of Serological Reactions, Harvard University Press, Cambridge.
25. Hersh, E. M., and S. E. Dyre. 1974. Cells binding the antigen keyhole limpet hemocyanin in the peripheral blood and in the lymphocyte cultures of non-immune and immunized human subjects. Clin. Exp. Immunol. 17:299.
26. , Snippe, H., A. J. van Houte, J. E. van Dam, M. J. De Reuver, M. Jansze, and J. M. Willers. 1983. Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoaiae type 3. Infect. Immun. 40:856.
27. Campo, M. S., B. W. O'Neil. G. J. Grindlay, F. Curtis, G. Knowles, and L. Chandrachud. 1997. A peptide encoding a B-cell epitope from the N-terminus of the capsid protein L2 of bovine papillomavirus-4 prevents disease. Virology 234:261.
28. Pervin, S., M. Chakraborty, M. Bhattacharya-Chatterjee, H. Zeytin, K. A. Foon, and S. K. Chatterjee. 1997. Induction of antitumor immunity by an anti-idiotype antibody mimicking carcinoembryonic antigen. Cancer Res, 57:728.
29. Kwak, L. W., H. A. Young, R. W. Pennington, and S. D. Weeks. 1996. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response. Proc. Natl. Acad. Sci. USA 93:10972.
30. Ragupathi, G., S. Cappello, S. S. Yi, D. Canter, M. Spassova, W. G. Bornmann, S. J. Danishefsky, and P. O. Livingston. 2002. Comparison of antibody titers after immunization with monovalent or tetravatent KLH conjugate vaccines. Vaccine 20:1030.
31. Ragupathi, G., P. P. Deshpande, D. M. Coltart, H. M. Kim, L. J. Williams, S. J. Danishefsky, and P. O. Livingston. 2002. Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies. Int. J. Cancer 99:207.
32. Maloy, W. L., A. M. Lew, R. W. Anderson, and J. E. Coligan, 1988. H-2K molecules have two different C-termini, one of which is K-region specific. Mol. Immunol. 25:453.
33. Zegers, N., K. Gerritse, C. Deen, W. Boersma, and E. Claassen. 1990. An improved conjugation method for controlled covalent coupling of synthetic peptides to proteins using glutaraldehyde in a dialysis method. J. Immunol. Methods 130:195.
34. Kozel, T. R., and J. Cazin, Jr. 1972. Immune response to Cryptococcus neoformans soluble polysaccharide. I. Serological assay for antigen and antibody. Infect. Immun. 5:35.
35. Dubois, M., K. A. Gilles, J. K. Hamilton, P. A. Rebers. and F. Smith. 1956. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28:350.
36. Hamilton. J. V., P. L. Chiodini, P. G. Fallon, and M. J. Doenhoff. 1999. Periodate-sensitive immunological cross-reactivity between keyhole limpet hemocyanin (KLH) and serodiagnostic Schistosoma mansoni egg antigens. Parasitology 118:83.
37. Casadevall, A., and M. D, Scharff. 1991. The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies. J. Exp. Med. 174:151.
38. Mukherjee, J., M. D. Scharff, and A. Casadevall. 1992. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60:4534.
39. Mukherjee, J., A. Casadevall, and M. D. Scharff. 1993. Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J. Exp. Med. 177:1105.
40. Mukherjee, J., L. A. Pirofski, M. D. Scharff, and A. Casadevall. 1993, Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proc. Natl. Acad. Sci. USA 90:3636.
41. Mukherjee, J., M. D. Scharff, and A. Casadevall. 1994. Cryptococcus neoformans infection can elicit protective antibodies in mice. Can. J. Microbiol. 40:888.
42. Yuan. R. R., G. Spira, J. Oh, M. Paizi, A. Casadevall, and M. D. Scharff. 1998. Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice. Infect. Immun. 66:1057.
43. Livingston, P. 1998. Ganglioside vaccines with emphasis on GM2. Semin. Oncol. 25:636.
44. Timmerman, J. M., and R. Levy. 2000. Linkage of foreign carrier protein to a self-tumor antigen enhances the immunogenicity of a pulsed dendritic cell vaccine. J. Immunol. 164:4797.
45. Kurokawa, T., M. Wuhrer, G. Lochnit, H. Geyer, J. Marki, and R. Geyer. 2002. Hemocyanin from the keyhole limpet Megathura crenulata (KLH) carries a novel type of N-glycans with Gat(β1-6)Man-motifs. Eur. J. Biochem. 269:5459.
46. Kantelhardt, S. R., M. Wuhrer, R. D. Dennis, M. J. Doenhoff, Q. Bickle, and R. Geyer. 2002. Fuc(α1→3)GalNAc-: major antigenic motif of Schistoma mansoni glycolipids implicated in infection sera and keyhole limpet hemocyanin cross-reactivity. Biochem. J. 366:217.
47. Harris, J. R., and J. Markl. 1999. Keyhole limpet hemocyanin (KLH): a biomedical review. Micron 30:597.
48. Olsson, C. A., R. Chute, and C. N. Rao. 1974. Immunologic reduction of bladder cancer recurrence rate. J. Urol. 111:173.
49. Wirguin, I., L. Suturkova-Milosevic, C. Briani, and N. Latov. 1995. Keyhole limpet hemocyanin contains Gal(β1-3)-GalNAc determinants that are cross-reactive with the T antigen. Cancer Immunol. Immunother. 40:307.
50. Lamm, D. L., J. I. Dehaven, and D. R. Riggs. 2000. Keyhole limpet hemocyanin immunotherapy of bladder cancer: laboratory and clinical studies. Eur. Urol. 37(Suppl. 3):41.
51. Wuhrer, M., R. D. Dennis, M. J. Doenhoff, and R. Geyer. 2000. A fucose-containing epitope is shared by keyhole limpet hemocyanin and Schistosoma mansoni glycosphingolipids. Mol. Biochem. Parasitol. 110:237.
52. Lambertucci, J. R. 1993. Acute schistosomiasis: clinical, diagnostic and therapeutic features. Rev. Inst. Med. Trop. Sao Paulo 35:399.
53. Woodward, M. P., W. W. Young, Jr., and R. A. Bloodgood. 1985. Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation. J. Immunol. Methods 78:143.
54. Devine, P. L., B. A. Clark, G. W. Birrell, G. T. Layton, B. G. Ward, P. F. Alewood, and I. F. McKenzie. 1991. The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is O-linked mucin carbohydrate containing N-glycolylneuraminic acid. Cancer Res. 51:5826.
55. Das, A., J. D. Higginbotham, and M. Heidelberger. 1972. Oxidation of the capsular polysaccharide of pneumococcal type IX by periodate, Biochem. J. 126:233.
56. Springer, G. F., and H. J. Yang. 1978. Effect of periodate oxidation on specific activities and carbohydrate components of human blood group N- and M-specific glycoproteins and glycopeptides. Vox Sang. 35:255.
57. Kabat, E. 1976. Structural Concepts in Immunology and Immunochemistry. Holt, Rinehart, and Winston, New York.
58. Swords, K. M., and L. A. Staehelin. 1993. Complementary immunotocalization patterns of cell wall hydroxyproline hydroxy roline-rich glycoproteins studied with the use of antibodies directed against different carbohydrate epitopes. Plant Physiol. 102:891.
59. Snapper, C. M., and J. J. Mond. 1993. Towards a comprehensive view of immunoglobulin class switching. Immunol. Today 14:15.
60. Thors, C., and E. Linder., 1998. Cross-reacting antibodies against keyhole limpet hemocyanin may interfere with the diagnostics of acute schistosomiasis. Parasite Immunol. 20:489.
61. Gao, W., and M. A. Pereira. 2001. Trypanosoma cruzi trans-sialidase potentiates T cell activation through antigen-presenting cells: role of IL-6 and Bruton's tyrosine kinase. Eur. J. Immunol. 31:1503.
62. Reina-San-Martin, B., A. Cosson, and P. Minoprio. 2000. Lymphocyte polyclonal activation: a pitfall for vaccine design against infectious agents. Parasitol. Today 16:62.
63. Herzenberg, L. A., T. Tokuhisa, and K. Hayakawa. 1983. Epitope-specific regulation. Annu. Rev. Immunol. 1:609.
64. Schutze, M. P., E. Deriaud, G. Przewlocki, and C. LeClerc. 1989. Carrier-induced epitopic suppression is initiated through clonal dominance. J. Immunol. 142:2635.
65. Feldmann, M., and J. W. Schrader. 1974. Mechanism of antigenic competition. II. Induction by specific T cell products. Cell. Immunol. 14:255.
66. Neveu, P. J. 1987. Are macrophages the target of antigenic competition between different epitopes of a hapten-carrier conjugate? Int. Arch. Allergy Appl. Immunol. 84:103.